4
Changes in Ownership
RECURSION PHARMACEUTICALS, INC. Filed Acc 0001628280-25-004088
Chief Financial Officer gave up 6,544 shares (to pay taxes)
- Chief Financial Officer acquired 48,940 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Taylor Ben R · Chief Financial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-03 | Grant or award : show line 1 in the form | +35,018 | 879,228 | D | ||
| 2025-02-03 | Grant or award : show line 2 in the form | +13,922 | 893,150 | D | ||
| 2025-02-03 | Shares withheld for taxes : show line 3 in the form | −6,544 | $7.25 | $47,444 | 886,606 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-03 | Grant or award : show line 4 in the form Stock Option (Right to Buy) | +70,037 | 70,037 | D |
Loading xslF345X05/wk-form4_1738792233.xml…